Nectar Lifesciences Limited (NSE:NECLIFE)
12.09
-0.36 (-2.89%)
Jun 1, 2026, 3:28 PM IST
Nectar Lifesciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,121 | 192.22 | 198.06 | 175.8 | 178.08 |
Short-Term Investments | 129.71 | - | - | - | - |
Trading Asset Securities | - | 5.3 | 4.95 | 3.14 | 4.6 |
Cash & Short-Term Investments | 1,251 | 197.52 | 203.01 | 178.94 | 182.68 |
Cash Growth | 533.38% | -2.70% | 13.45% | -2.05% | -29.73% |
Accounts Receivable | - | 3,455 | 3,792 | 2,796 | 4,470 |
Other Receivables | - | 459.73 | 423.11 | 637.78 | 670.53 |
Receivables | 0.91 | 3,923 | 4,224 | 3,438 | 5,144 |
Inventory | 2.98 | 7,423 | 7,765 | 7,315 | 7,213 |
Other Current Assets | 1,633 | 832.25 | 645.76 | 1,380 | 1,009 |
Total Current Assets | 2,888 | 12,376 | 12,838 | 12,312 | 13,548 |
Property, Plant & Equipment | 1,034 | 6,333 | 6,561 | 6,904 | 7,652 |
Long-Term Investments | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
Goodwill | 11.12 | - | - | - | - |
Other Intangible Assets | - | 565.04 | 523.93 | 493.29 | 430.21 |
Long-Term Accounts Receivable | - | 84.87 | 81.54 | 73.46 | 78.28 |
Long-Term Deferred Tax Assets | 2,245 | 550.41 | 74.78 | 205.69 | 28 |
Other Long-Term Assets | 34.84 | 560.38 | 1,829 | 1,901 | 2,169 |
Total Assets | 6,216 | 20,472 | 21,911 | 21,892 | 23,908 |
Accounts Payable | - | 4,381 | 4,197 | 3,188 | 3,767 |
Accrued Expenses | 0.07 | 151.35 | 153.5 | 104.43 | 510.46 |
Short-Term Debt | - | 4,402 | 4,122 | 4,589 | 5,028 |
Current Portion of Long-Term Debt | - | 816.8 | 830.09 | 684.45 | 660.81 |
Other Current Liabilities | 301.07 | 463.95 | 425.78 | 343.74 | 72.85 |
Total Current Liabilities | 301.14 | 10,215 | 9,728 | 8,909 | 10,038 |
Long-Term Debt | - | 601.27 | 1,403 | 2,265 | 2,911 |
Long-Term Unearned Revenue | - | 7.21 | 7.46 | 7.71 | 7.96 |
Pension & Post-Retirement Benefits | 0.05 | 87.28 | 79.37 | 64.46 | 63.93 |
Other Long-Term Liabilities | 91.92 | 0.01 | -0.01 | 0.01 | 8.3 |
Total Liabilities | 393.11 | 10,911 | 11,218 | 11,246 | 13,029 |
Common Stock | 194.26 | 224.26 | 224.26 | 224.26 | 224.26 |
Additional Paid-In Capital | - | 3,288 | 3,288 | 3,288 | 3,288 |
Retained Earnings | - | 6,049 | 7,180 | 7,134 | 7,367 |
Comprehensive Income & Other | 5,629 | - | - | - | - |
Shareholders' Equity | 5,823 | 9,561 | 10,692 | 10,646 | 10,879 |
Total Liabilities & Equity | 6,216 | 20,472 | 21,911 | 21,892 | 23,908 |
Total Debt | - | 5,820 | 6,355 | 7,538 | 8,599 |
Net Cash (Debt) | 1,251 | -5,623 | -6,152 | -7,359 | -8,417 |
Net Cash Per Share | 5.72 | -25.07 | -27.43 | -32.82 | -37.53 |
Filing Date Shares Outstanding | 200.96 | 224.26 | 224.26 | 224.26 | 224.26 |
Total Common Shares Outstanding | 200.96 | 224.26 | 224.26 | 224.26 | 224.26 |
Working Capital | 2,587 | 2,160 | 3,110 | 3,403 | 3,510 |
Book Value Per Share | 28.98 | 42.63 | 47.68 | 47.47 | 48.51 |
Tangible Book Value | 5,812 | 8,996 | 10,169 | 10,153 | 10,449 |
Tangible Book Value Per Share | 28.92 | 40.11 | 45.34 | 45.27 | 46.59 |
Land | - | 192.35 | 192.35 | 192.35 | 516.05 |
Buildings | - | 1,818 | 1,803 | 1,760 | 1,773 |
Machinery | - | 10,451 | 10,186 | 10,011 | 9,936 |
Construction In Progress | - | 567.28 | 657.5 | 777.83 | 850.98 |